McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Dominic J. Caruso
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Lynne M. Doughtie
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: W. Roy Dunbar
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Deborah Dunsire, M.D.
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Julie L. Gerberding, M.D., M.P.H.
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: James H. Hinton
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Donald R. Knauss
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Bradley E. Lerman
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Maria N. Martinez
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Kevin M. Ozan
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Brian S. Tyler
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Election of Twelve Directors for a One-Year Term: Kathleen Wilson-Thompson
DIRECTOR ELECTIONS
ISSUER
6735.000000
0
FOR
6735.000000
FOR
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026
AUDIT-RELATED
ISSUER
6735.000000
0
AGAINST
6735.000000
AGAINST
McKesson Corporation
58155Q103
US58155Q1031
07/30/2025
Advisory Vote to Approve the Company's Executive Compensation
SECTION 14A SAY-ON-PAY VOTES
ISSUER
6735.000000
0
AGAINST
6735.000000
AGAINST
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): John P. Groetelaars
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): William R. Jellison
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Joon S. Lee, M.D.
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D.
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell
DIRECTOR ELECTIONS
ISSUER
365043.000000
0
AGAINST
365043.000000
AGAINST
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;
AUDIT-RELATED
ISSUER
365043.000000
0
AGAINST
365043.000000
AGAINST
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Approving, on an advisory basis, the Company's executive compensation;
SECTION 14A SAY-ON-PAY VOTES
ISSUER
365043.000000
0
AGAINST
365043.000000
AGAINST
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Renewing the Board of Directors' authority to issue shares under Irish law;
CAPITAL STRUCTURE
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law;
CAPITAL STRUCTURE
ISSUER
365043.000000
0
AGAINST
365043.000000
AGAINST
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares;
CAPITAL STRUCTURE
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Approving an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves;
CAPITAL STRUCTURE
CORPORATE GOVERNANCE
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and
CAPITAL STRUCTURE
ISSUER
365043.000000
0
FOR
365043.000000
FOR
Medtronic plc
G5960L103
IE00BTN1Y115
10/16/2025
Approving amendments to the Company's Articles of Association, to update the advance notice provisions.
SHAREHOLDER RIGHTS AND DEFENSES
ISSUER
365043.000000
0
FOR
365043.000000
FOR
I-Mab
44975P103
US44975P1030
10/24/2025
Approve Change of English Name of the Company and Adopt Chinese Name as its New Dual Foreign Name
CORPORATE GOVERNANCE
ISSUER
43738.000000
0
FOR
43738.000000
FOR
I-Mab
44975P103
US44975P1030
10/24/2025
Amend Memorandum and Articles of Association
CORPORATE GOVERNANCE
ISSUER
43738.000000
0
FOR
43738.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Carol Burt
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Christopher DelOrefice
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Jan De Witte
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Karen Drexler
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Michael Farrell
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Peter Farrell
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Harjit Gill
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: John Hernandez
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Nicole Mowad-Nassar
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Desney Tan
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Ronald Taylor
DIRECTOR ELECTIONS
ISSUER
16139.000000
0
AGAINST
16139.000000
AGAINST
ResMed Inc.
761152107
US7611521078
11/19/2025
Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026.
AUDIT-RELATED
ISSUER
16139.000000
0
AGAINST
16139.000000
AGAINST
ResMed Inc.
761152107
US7611521078
11/19/2025
Approve, on an advisory basis, the compensation paid to our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
16139.000000
0
AGAINST
16139.000000
AGAINST
ResMed Inc.
761152107
US7611521078
11/19/2025
Approve the amendment and restatement of our 2009 Incentive Award Plan.
COMPENSATION
ISSUER
16139.000000
0
FOR
16139.000000
FOR
ResMed Inc.
761152107
US7611521078
11/19/2025
Approve the amendment and restatement of our 2018 Employee Stock Purchase Plan.
COMPENSATION
ISSUER
16139.000000
0
FOR
16139.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: William M. Brown
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Carrie L. Byington
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: R. Andrew Eckert
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Claire M. Fraser
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
AGAINST
115741.000000
AGAINST
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Gregory J. Hayes
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Jeffrey W. Henderson
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Robert L. Huffines
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Christopher Jones
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Thomas E. Polen
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Timothy M. Ring
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Bertram L. Scott
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
AGAINST
115741.000000
AGAINST
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Joanne Waldstreicher
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Election of Directors: Jacqueline Wright
DIRECTOR ELECTIONS
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Ratification of the selection of the independent registered public accounting firm
AUDIT-RELATED
ISSUER
115741.000000
0
AGAINST
115741.000000
AGAINST
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Advisory vote to approve named executive officer compensation
SECTION 14A SAY-ON-PAY VOTES
ISSUER
115741.000000
0
AGAINST
115741.000000
AGAINST
Becton, Dickinson and Company
075887109
US0758871091
01/27/2026
Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan
COMPENSATION
ISSUER
115741.000000
0
FOR
115741.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Raquel C. Bono, M.D.
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Frank A. D'Amelio
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
AGAINST
48838.000000
AGAINST
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: David T. Feinberg, M.D.
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Wayne A. I. Frederick, M.D.
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Kurt J. Hilzinger
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
AGAINST
48838.000000
AGAINST
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Karen W. Katz
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Marcy S. Klevorn
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Jorge S. Mesquita
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: James A. Rechtin
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
Election of Directors: Gordon Smith
DIRECTOR ELECTIONS
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.
AUDIT-RELATED
ISSUER
48838.000000
0
AGAINST
48838.000000
AGAINST
Humana Inc.
444859102
US4448591028
04/16/2026
Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
48838.000000
0
AGAINST
48838.000000
AGAINST
Humana Inc.
444859102
US4448591028
04/16/2026
The approval of the Humana Inc. 2026 Stock Incentive Plan.
COMPENSATION
ISSUER
48838.000000
0
FOR
48838.000000
FOR
Humana Inc.
444859102
US4448591028
04/16/2026
The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting.
COMPENSATION
SECURITY HOLDER
48838.000000
0
FOR
48838.000000
AGAINST
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Thomas F. Frist III
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
AGAINST
5667.000000
AGAINST
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Samuel N. Hazen
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: John W. Chidsey, III
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Nancy-Ann DeParle
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: William R. Frist
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
AGAINST
5667.000000
AGAINST
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Hugh F. Johnston
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Michael W. Michelson
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Wayne J. Riley, M.D.
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Election of Directors: Andrea B. Smith
DIRECTOR ELECTIONS
ISSUER
5667.000000
0
FOR
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
5667.000000
0
AGAINST
5667.000000
AGAINST
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Advisory vote to approve named executive officer compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
5667.000000
0
AGAINST
5667.000000
AGAINST
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences.
OTHER SOCIAL ISSUES
SECURITY HOLDER
5667.000000
0
AGAINST
5667.000000
FOR
HCA Healthcare, Inc.
40412C101
US40412C1018
04/23/2026
Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent.
CORPORATE GOVERNANCE
SECURITY HOLDER
5667.000000
0
AGAINST
5667.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): Ari Bousbib
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): Carol J. Burt
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): John G. Danhakl
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): James A. Fasano
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): Colleen A. Goggins
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): William G. Kaelin Jr., M.D.
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): John M. Leonard, M.D.
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): Leslie Wims Morris
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
The election of each of the director nominees listed below (a through i): Sheila A. Stamps
DIRECTOR ELECTIONS
ISSUER
19723.000000
0
FOR
19723.000000
FOR
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).
SECTION 14A SAY-ON-PAY VOTES
ISSUER
19723.000000
0
AGAINST
19723.000000
AGAINST
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026.
AUDIT-RELATED
ISSUER
19723.000000
0
AGAINST
19723.000000
AGAINST
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan.
COMPENSATION
ISSUER
19723.000000
0
AGAINST
19723.000000
AGAINST
IQVIA Holdings Inc.
46266C105
US46266C1053
04/23/2026
If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles.
CORPORATE GOVERNANCE
SECURITY HOLDER
19723.000000
0
FOR
19723.000000
AGAINST
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: N. Ahuja
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: C. Babineaux-Fontenot
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: S. E. Blount
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: R. B. Ford
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: P. Gonzalez
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: M. A. Kumbier
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: D. W. McDew
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: N. McKinstry
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: M. G. O'Grady
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: M. F. Roman
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: D. J. Starks
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Election of 12 Directors: J. G. Stratton
DIRECTOR ELECTIONS
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Ratification of Ernst & Young LLP As Auditors
AUDIT-RELATED
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Say on Pay - An Advisory Vote on the Approval of Executive Compensation
SECTION 14A SAY-ON-PAY VOTES
ISSUER
406053.000000
0
AGAINST
406053.000000
AGAINST
Abbott Laboratories
002824100
US0028241000
04/24/2026
Approval of the Abbott Laboratories 2026 Incentive Stock Program
COMPENSATION
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Abbott Laboratories
002824100
US0028241000
04/24/2026
Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees
COMPENSATION
ISSUER
406053.000000
0
FOR
406053.000000
FOR
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Robert L. Zerbe
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
WITHHOLD
239509.000000
AGAINST
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Alan L. Rubino
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
WITHHOLD
239509.000000
AGAINST
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Heidi Hagen
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
FOR
239509.000000
FOR
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Kevin F. McLaughlin
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
FOR
239509.000000
FOR
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Paul K. Wotton
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
FOR
239509.000000
FOR
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Dominick C. Colangelo
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
FOR
239509.000000
FOR
Vericel Corporation
92346J108
US92346J1088
04/29/2026
Election of Directors: Lisa Wright
DIRECTOR ELECTIONS
ISSUER
239509.000000
0
FOR
239509.000000
FOR
Vericel Corporation
92346J108
US92346J1088
04/29/2026
To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
239509.000000
0
AGAINST
239509.000000
AGAINST
Vericel Corporation
92346J108
US92346J1088
04/29/2026
To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
239509.000000
0
AGAINST
239509.000000
AGAINST
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: David C. Habiger
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Edward J. Ludwig
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Michael F. Mahoney
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Jessica L. Mega
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Susan E. Morano
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Cheryl Pegus
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Cathy R. Smith
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Christophe P. Weber
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: David S. Wichmann
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Proposal to elect ten Directors: Ellen M. Zane
DIRECTOR ELECTIONS
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
238022.000000
0
AGAINST
238022.000000
AGAINST
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.
AUDIT-RELATED
ISSUER
238022.000000
0
AGAINST
238022.000000
AGAINST
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.
COMPENSATION
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
To amend our Certificate of Incorporation to remove supermajority voting provisions.
CORPORATE GOVERNANCE
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.
CORPORATE GOVERNANCE
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders.
CORPORATE GOVERNANCE
ISSUER
238022.000000
0
FOR
238022.000000
FOR
Boston Scientific Corporation
101137107
US1011371077
04/30/2026
Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."
CORPORATE GOVERNANCE
SECURITY HOLDER
238022.000000
0
FOR
238022.000000
AGAINST
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: Scott M. Brinker
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: Katherine M. Sandstrom
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: John T. Thomas
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: Brian G. Cartwright
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: James B. Connor
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: R. Kent Griffin, Jr.
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: Sara G. Lewis
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: Ava E. Lias-Booker
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Election of Directors: Richard A. Weiss
DIRECTOR ELECTIONS
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Approval of 2025 executive compensation on an advisory basis.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
534110.000000
0
AGAINST
534110.000000
AGAINST
Healthpeak Properties, Inc.
42250P103
US42250P1030
04/30/2026
Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
534110.000000
0
FOR
534110.000000
FOR
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Election of Class II Directors: Gary L. Ellis
DIRECTOR ELECTIONS
ISSUER
203308.000000
0
WITHHOLD
203308.000000
AGAINST
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Election of Class II Directors: Georgia Melenikiotou
DIRECTOR ELECTIONS
ISSUER
203308.000000
0
FOR
203308.000000
FOR
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Election of Class II Directors: Dana G. Mead, Jr.
DIRECTOR ELECTIONS
ISSUER
203308.000000
0
WITHHOLD
203308.000000
AGAINST
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026.
AUDIT-RELATED
ISSUER
203308.000000
0
FOR
203308.000000
FOR
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
203308.000000
0
FOR
203308.000000
FOR
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
203308.000000
0
ONE YEAR
203308.000000
FOR
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders.
SHAREHOLDER RIGHTS AND DEFENSES
ISSUER
203308.000000
0
FOR
203308.000000
FOR
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan.
COMPENSATION
ISSUER
203308.000000
0
AGAINST
203308.000000
AGAINST
Inspire Medical Systems, Inc.
457730109
US4577301090
04/30/2026
Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6.
CORPORATE GOVERNANCE
ISSUER
203308.000000
0
FOR
203308.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Craig H. Barratt, Ph.D.
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Joseph C. Beery
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Lewis Chew
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Gary S. Guthart, Ph.D.
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
AGAINST
64078.000000
AGAINST
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Sreelakshmi Kolli
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Amy L. Ladd, M.D.
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Keith R. Leonard, Jr.
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Jami Dover Nachtsheim
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: Monica P. Reed, M.D.
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
Election of Directors: David J. Rosa
DIRECTOR ELECTIONS
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
To approve, by advisory vote, the compensation of the Company's Named Executive Officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
64078.000000
0
AGAINST
64078.000000
AGAINST
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Intuitive Surgical, Inc.
46120E602
US46120E6023
04/30/2026
To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan.
COMPENSATION
ISSUER
64078.000000
0
FOR
64078.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Election of the following directors, each to serve a three-year term: Carolyn Bertozzi
DIRECTOR ELECTIONS
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Election of the following directors, each to serve a three-year term: William Kaelin, Jr.
DIRECTOR ELECTIONS
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Election of the following directors, each to serve a three-year term: Jon Moeller
DIRECTOR ELECTIONS
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Election of the following directors, each to serve a three-year term: David Ricks
DIRECTOR ELECTIONS
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Approval, on an advisory basis, of the compensation paid to the company's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026.
AUDIT-RELATED
ISSUER
31480.000000
0
AGAINST
31480.000000
AGAINST
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Approval of amendments to the company's articles of incorporation to eliminate the classified board structure.
SHAREHOLDER RIGHTS AND DEFENSES
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions.
CORPORATE GOVERNANCE
ISSUER
31480.000000
0
FOR
31480.000000
FOR
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.
CORPORATE GOVERNANCE
SECURITY HOLDER
31480.000000
0
FOR
31480.000000
AGAINST
Eli Lilly and Company
532457108
US5324571083
05/04/2026
Shareholder proposal to prepare an annual lobbying report.
OTHER SOCIAL ISSUES
SECURITY HOLDER
31480.000000
0
AGAINST
31480.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Peter J. Arduini
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A.
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Christopher S. Boerner, Ph.D.
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Julia A. Haller, M.D.
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D.
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Michael R. McMullen
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Paula A. Price
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Derica W. Rice
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Theodore R. Samuels
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Karen H. Vousden, Ph.D.
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Election of Directors: Phyllis R. Yale
DIRECTOR ELECTIONS
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Advisory Vote to Approve the Compensation of our Named Executive Officers
SECTION 14A SAY-ON-PAY VOTES
ISSUER
369546.000000
0
AGAINST
369546.000000
AGAINST
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Vote to Approve the Company's 2026 Stock Award and Incentive Plan
COMPENSATION
ISSUER
369546.000000
0
FOR
369546.000000
FOR
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Ratification of the Appointment of an Independent Registered Public Accounting Firm
AUDIT-RELATED
ISSUER
369546.000000
0
AGAINST
369546.000000
AGAINST
Bristol-Myers Squibb Company
110122108
US1101221083
05/05/2026
Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director
CORPORATE GOVERNANCE
SECURITY HOLDER
369546.000000
0
FOR
369546.000000
AGAINST
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Nancy C. Andrews
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Steven Barg
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Abraham Ceesay
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Mark Enyedy
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: James C. Foster
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Birgit Girshick
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Paul Graves
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Reshema Kemps-Polanco
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: George Llado
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Martin Mackay
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Craig B. Thompson
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Election of Directors: Virginia Wilson
DIRECTOR ELECTIONS
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Advisory Approval of 2025 Executive Officer Compensation
SECTION 14A SAY-ON-PAY VOTES
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
2026 Long-Term Incentive Plan
COMPENSATION
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Charles River Laboratories International, Inc.
159864107
US1598641074
05/05/2026
Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026
AUDIT-RELATED
ISSUER
32984.000000
0
FOR
32984.000000
FOR
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
FOR
150922.000000
FOR
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
FOR
150922.000000
FOR
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
FOR
150922.000000
FOR
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
FOR
150922.000000
FOR
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
FOR
150922.000000
FOR
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D.
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD
DIRECTOR ELECTIONS
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To approve on an advisory basis the Company's named executive officer compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
150922.000000
0
AGAINST
150922.000000
AGAINST
Danaher Corporation
235851102
US2358511028
05/05/2026
To approve the Company's Amended and Restated Omnibus Incentive Plan.
COMPENSATION
ISSUER
150922.000000
0
FOR
150922.000000
FOR
Acadia Healthcare Company, Inc.
00404A109
US00404A1097
05/06/2026
Election of Directors: Michael J. Fucci
DIRECTOR ELECTIONS
ISSUER
335036.000000
0
FOR
335036.000000
FOR
Acadia Healthcare Company, Inc.
00404A109
US00404A1097
05/06/2026
Election of Directors: Patrice A. Harris, M.D., M.A.
DIRECTOR ELECTIONS
ISSUER
335036.000000
0
FOR
335036.000000
FOR
Acadia Healthcare Company, Inc.
00404A109
US00404A1097
05/06/2026
Election of Directors: Daniel J. Cancelmi
DIRECTOR ELECTIONS
ISSUER
335036.000000
0
FOR
335036.000000
FOR
Acadia Healthcare Company, Inc.
00404A109
US00404A1097
05/06/2026
Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan.
COMPENSATION
ISSUER
335036.000000
0
FOR
335036.000000
FOR
Acadia Healthcare Company, Inc.
00404A109
US00404A1097
05/06/2026
Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
335036.000000
0
AGAINST
335036.000000
AGAINST
Acadia Healthcare Company, Inc.
00404A109
US00404A1097
05/06/2026
Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
335036.000000
0
AGAINST
335036.000000
AGAINST
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Barbara L. Brasier
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Leo P. Grohowski
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Stephen H. Lockhart
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Steven J. Orlando
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
AGAINST
55522.000000
AGAINST
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Ronna E. Romney
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
AGAINST
55522.000000
AGAINST
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Richard M. Schapiro
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Francis S. Soistman
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Dale B. Wolf
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Richard C. Zoretic
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To elect ten directors to hold office until the 2027 Annual Meeting: Joseph M. Zubretsky
DIRECTOR ELECTIONS
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
55522.000000
0
AGAINST
55522.000000
AGAINST
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.
AUDIT-RELATED
ISSUER
55522.000000
0
AGAINST
55522.000000
AGAINST
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan.
COMPENSATION
ISSUER
55522.000000
0
AGAINST
55522.000000
AGAINST
Molina Healthcare, Inc.
60855R100
US60855R1005
05/06/2026
To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings.
CORPORATE GOVERNANCE
ISSUER
55522.000000
0
FOR
55522.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Mary K. Brainerd
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Giovanni Caforio, M.D.
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Kevin A. Lobo
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Emmanuel P. Maceda
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Sherilyn S. McCoy
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Rachel M. Ruggeri
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Andrew K. Silvernail
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Lisa M. Skeete Tatum
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Ronda E. Stryker
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
AGAINST
21884.000000
AGAINST
Stryker Corporation
863667101
US8636671013
05/06/2026
Election Directors: Rajeev Suri
DIRECTOR ELECTIONS
ISSUER
21884.000000
0
FOR
21884.000000
FOR
Stryker Corporation
863667101
US8636671013
05/06/2026
Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026.
AUDIT-RELATED
ISSUER
21884.000000
0
AGAINST
21884.000000
AGAINST
Stryker Corporation
863667101
US8636671013
05/06/2026
Advisory Vote to Approve Named Executive Officer Compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
21884.000000
0
AGAINST
21884.000000
AGAINST
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: Peter J. Arduini
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: H. Lawrence Culp, Jr.
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: Rodney F. Hochman
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: Catherine Lesjak
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: Kevin A. Lobo
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: Anne T. Madden
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: William J. Stromberg
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Election of Directors: Phoebe L. Yang
DIRECTOR ELECTIONS
ISSUER
95461.000000
0
FOR
95461.000000
FOR
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Approval of our named executive officers' compensation in an advisory vote.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
95461.000000
0
AGAINST
95461.000000
AGAINST
GE Healthcare Technologies, Inc.
36266G107
US36266G1076
05/07/2026
Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026,
AUDIT-RELATED
ISSUER
95461.000000
0
FOR
95461.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Election of Class II Directors: Jennifer L. Davis
DIRECTOR ELECTIONS
ISSUER
221625.000000
0
FOR
221625.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Election of Class II Directors: Melody B. Meyer
DIRECTOR ELECTIONS
ISSUER
221625.000000
0
FOR
221625.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Election of Class II Directors: Robert A. Michael
DIRECTOR ELECTIONS
ISSUER
221625.000000
0
FOR
221625.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Election of Class II Directors: Frederick H. Waddell
DIRECTOR ELECTIONS
ISSUER
221625.000000
0
FOR
221625.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026
AUDIT-RELATED
ISSUER
221625.000000
0
FOR
221625.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Say on Pay - An advisory vote on the approval of executive compensation
SECTION 14A SAY-ON-PAY VOTES
ISSUER
221625.000000
0
AGAINST
221625.000000
AGAINST
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting
CORPORATE GOVERNANCE
ISSUER
221625.000000
0
FOR
221625.000000
FOR
AbbVie Inc.
00287Y109
US00287Y1091
05/08/2026
Stockholder Proposal - to Adopt a Policy to Require an Independent Chair
CORPORATE GOVERNANCE
SECURITY HOLDER
221625.000000
0
FOR
221625.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Financial Statements and Statutory Reports
CORPORATE GOVERNANCE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Consolidated Financial Statements and Statutory Reports
CORPORATE GOVERNANCE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Treatment of Losses
CAPITAL STRUCTURE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions
CORPORATE GOVERNANCE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Reelect Sylvie Gregoire as Director
DIRECTOR ELECTIONS
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Reelect June Lee as Director
DIRECTOR ELECTIONS
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Reelect Troy Ignelzi as Director
DIRECTOR ELECTIONS
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Compensation Report
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Compensation of Sylvie Gregoire, Chairwoman of the Board
SECTION 14A SAY-ON-PAY VOTES
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Compensation of Marc de Garidel, CEO
SECTION 14A SAY-ON-PAY VOTES
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Compensation Report of Corporate Officers
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Remuneration Policy of Chairwoman of the Board
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Remuneration Policy of CEO
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Remuneration Policy of Directors
COMPENSATION
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Repurchase of Up to 10 Percent of Issued Share Capital
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
CAPITAL STRUCTURE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line on the American Market, up to Aggregate Nominal Amount of EUR 20,000
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 237,873.56
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Capitalization of Reserves of Up to EUR 750,000 for Bonus Issue or Increase in Par Value
CAPITAL STRUCTURE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 17-22 and 25-26 at EUR 750,000
CAPITAL STRUCTURE
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans
COMPENSATION
ISSUER
60509.000000
0
AGAINST
60509.000000
AGAINST
Abivax SA
00370M103
US00370M1036
05/11/2026
Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 28-30, at 10 Percent of Issued Capital
CAPITAL STRUCTURE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Capital Issuances for Use in Employee Stock Purchase Plans
COMPENSATION
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Abivax SA
00370M103
US00370M1036
05/11/2026
Authorize Filing of Required Documents/Other Formalities
CORPORATE GOVERNANCE
ISSUER
60509.000000
0
FOR
60509.000000
FOR
Elevance Health, Inc.
036752103
US0367521038
05/13/2026
Election of Directors: Gail K. Boudreaux
DIRECTOR ELECTIONS
ISSUER
52261.000000
0
FOR
52261.000000
FOR
Elevance Health, Inc.
036752103
US0367521038
05/13/2026
Election of Directors: Robert L. Dixon, Jr.
DIRECTOR ELECTIONS
ISSUER
52261.000000
0
FOR
52261.000000
FOR
Elevance Health, Inc.
036752103
US0367521038
05/13/2026
Election of Directors: Deanna D. Strable
DIRECTOR ELECTIONS
ISSUER
52261.000000
0
FOR
52261.000000
FOR
Elevance Health, Inc.
036752103
US0367521038
05/13/2026
Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").
SECTION 14A SAY-ON-PAY VOTES
ISSUER
52261.000000
0
AGAINST
52261.000000
AGAINST
Elevance Health, Inc.
036752103
US0367521038
05/13/2026
Ratification of Ernst & Young LLP as Auditors for 2026.
AUDIT-RELATED
ISSUER
52261.000000
0
AGAINST
52261.000000
AGAINST
Elevance Health, Inc.
036752103
US0367521038
05/13/2026
Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups.
OTHER SOCIAL ISSUES
SECURITY HOLDER
52261.000000
0
AGAINST
52261.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Accept Financial Statements and Statutory Reports
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Treatment of Net Loss
CAPITAL STRUCTURE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Discharge of Board and Senior Management
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Anthony Rosenberg as Director and Board Chair
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Christina Ackermann as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Lionel Carnot as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Arshad Khanani as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Martijn Kleijwegt as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Geraldine O'Keeffe as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Riad Sherif as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reelect Robert Warner as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Elect Gregory Perry as Director
DIRECTOR ELECTIONS
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Reappoint Lionel Carnot as Member of the Compensation Committee
DIRECTOR ELECTIONS
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Appoint Geraldine O'Keeffe as Member of the Compensation Committee
DIRECTOR ELECTIONS
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Appoint Gregory Perry as Member of the Compensation Committee
DIRECTOR ELECTIONS
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Ratify PricewaterhouseCoopers SA as Statutory Auditors
AUDIT-RELATED
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Designate Blum & Partner AG as Independent Proxy
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Fixed Remuneration of Directors in the Amount of USD 572,000
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Equity-Based Remuneration of Directors in the Amount of USD 2.2 Million
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Fixed Remuneration of Executive Committee in the Amount of USD 2.5 Million
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Variable Remuneration of Executive Committee in the Amount of USD 1.8 Million
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Equity-Based Remuneration of Executive Committee in the Amount of USD 18 Million
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Remuneration Report (Non-Binding)
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Creation of Capital Band within the Upper Limit of CHF 930,626.64 and the Lower Limit of CHF 620,417.76 with or without Exclusion of Preemptive Rights
CAPITAL STRUCTURE
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Approve Creation of CHF 126,777 Pool of Conditional Capital for Employee Equity Plans
COMPENSATION
ISSUER
569796.000000
0
FOR
569796.000000
FOR
Oculis Holding AG
H5870P102
CH1242303498
05/13/2026
Transact Other Business (Voting)
CORPORATE GOVERNANCE
ISSUER
569796.000000
0
AGAINST
569796.000000
AGAINST
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Melody C. Barnes
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Theodore R. Bigman
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Debra A. Cafaro
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Michael J. Embler
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Matthew J. Lustig
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Roxanne M. Martino
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Marguerite M. Nader
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Sean P. Nolan
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Walter C. Rakowich
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Joe V. Rodriguez, Jr.
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Sumit Roy
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Election of Directors of Ventas, Inc.: Maurice S. Smith
DIRECTOR ELECTIONS
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
121336.000000
0
FOR
121336.000000
FOR
Ventas, Inc.
92276F100
US92276F1003
05/13/2026
Ratification of the selection of KPMG LLP as independent registered public accounting firm of Ventas, Inc. for fiscal year 2026.
AUDIT-RELATED
ISSUER
121336.000000
0
FOR
121336.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Fernando Aguirre
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Jeffrey R. Balser, M.D., Ph.D.
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: C. David Brown II
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
AGAINST
225900.000000
AGAINST
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Alecia A. DeCoudreaux
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Anne M. Finucane
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: John E. Gallina
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: J. David Joyner
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: J. Scott Kirby
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Michael F. Mahoney
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Leslie V. Norwalk
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Larry M. Robbins
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Guy P. Sansone
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Election of Directors: Douglas H. Shulman
DIRECTOR ELECTIONS
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026.
AUDIT-RELATED
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
225900.000000
0
AGAINST
225900.000000
AGAINST
CVS Health Corporation
126650100
US1266501006
05/14/2026
Proposal to Approve the Company's 2026 Incentive Compensation Plan.
COMPENSATION
ISSUER
225900.000000
0
FOR
225900.000000
FOR
CVS Health Corporation
126650100
US1266501006
05/14/2026
Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.
CORPORATE GOVERNANCE
SECURITY HOLDER
225900.000000
0
AGAINST
225900.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Olivier Loeillot
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
FOR
54330.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Karen A. Dawes
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
AGAINST
54330.000000
AGAINST
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Nicolas M. Barthelemy
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
FOR
54330.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Carrie Eglinton Manner
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
AGAINST
54330.000000
AGAINST
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Konstantin Konstantinov, Ph.D.
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
FOR
54330.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Martin D. Madaus, D.V.M., Ph.D.
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
FOR
54330.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Rohin Mhatre, Ph.D.
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
FOR
54330.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Glenn P. Muir
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
AGAINST
54330.000000
AGAINST
Repligen Corporation
759916109
US7599161095
05/14/2026
Election of Directors: Margaret A. Pax
DIRECTOR ELECTIONS
ISSUER
54330.000000
0
FOR
54330.000000
FOR
Repligen Corporation
759916109
US7599161095
05/14/2026
Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
54330.000000
0
AGAINST
54330.000000
AGAINST
Repligen Corporation
759916109
US7599161095
05/14/2026
Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
54330.000000
0
AGAINST
54330.000000
AGAINST
Biodesix, Inc.
09075X207
US09075X2071
05/19/2026
To elect the two Class III directors named in this proxy statement to hold office until the 2029 annual meeting of stockholders: Jean Franchi
DIRECTOR ELECTIONS
ISSUER
394100.000000
0
WITHHOLD
394100.000000
AGAINST
Biodesix, Inc.
09075X207
US09075X2071
05/19/2026
To elect the two Class III directors named in this proxy statement to hold office until the 2029 annual meeting of stockholders: Hany Massarany
DIRECTOR ELECTIONS
ISSUER
394100.000000
0
FOR
394100.000000
FOR
Biodesix, Inc.
09075X207
US09075X2071
05/19/2026
To approve, on a non-binding advisory basis, the compensation of our named executive officers;
SECTION 14A SAY-ON-PAY VOTES
ISSUER
394100.000000
0
FOR
394100.000000
FOR
Biodesix, Inc.
09075X207
US09075X2071
05/19/2026
To approve, on a non-binding advisory basis, the frequency of solicitation of advisory votes to approve named executive officer compensation;
SECTION 14A SAY-ON-PAY VOTES
ISSUER
394100.000000
0
ONE YEAR
394100.000000
FOR
Biodesix, Inc.
09075X207
US09075X2071
05/19/2026
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026;
AUDIT-RELATED
ISSUER
394100.000000
0
FOR
394100.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
Election of Directors: Thomas N. Bohjalian
DIRECTOR ELECTIONS
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
Election of Directors: David B. Henry
DIRECTOR ELECTIONS
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
Election of Directors: Constance B. Moore
DIRECTOR ELECTIONS
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
Election of Directors: Glenn Rufrano
DIRECTOR ELECTIONS
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
Election of Directors: Peter A. Scott
DIRECTOR ELECTIONS
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
Election of Directors: Donald C. Wood
DIRECTOR ELECTIONS
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2026 fiscal year.
AUDIT-RELATED
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Healthcare Realty Trust Incorporated
42226K105
US42226K1051
05/19/2026
To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2026 Annual Meeting of Stockholders.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
77778.000000
0
FOR
77778.000000
FOR
Insulet Corporation
45784P101
US45784P1012
05/20/2026
Election of Directors: Luciana Borio
DIRECTOR ELECTIONS
ISSUER
62860.000000
0
FOR
62860.000000
FOR
Insulet Corporation
45784P101
US45784P1012
05/20/2026
Election of Directors: Michael R. Minogue
DIRECTOR ELECTIONS
ISSUER
62860.000000
0
FOR
62860.000000
FOR
Insulet Corporation
45784P101
US45784P1012
05/20/2026
Election of Directors: Timothy C. Stonesifer
DIRECTOR ELECTIONS
ISSUER
62860.000000
0
FOR
62860.000000
FOR
Insulet Corporation
45784P101
US45784P1012
05/20/2026
To approve, on a non-binding, advisory basis, the compensation of certain executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
62860.000000
0
AGAINST
62860.000000
AGAINST
Insulet Corporation
45784P101
US45784P1012
05/20/2026
To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
62860.000000
0
FOR
62860.000000
FOR
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Cornelia Cheng
DIRECTOR ELECTIONS
ISSUER
139352.000000
0
FOR
139352.000000
FOR
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: David L. Gruber
DIRECTOR ELECTIONS
ISSUER
139352.000000
0
FOR
139352.000000
FOR
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Jeffrey C. Hawken
DIRECTOR ELECTIONS
ISSUER
139352.000000
0
FOR
139352.000000
FOR
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Bradley J. Preber
DIRECTOR ELECTIONS
ISSUER
139352.000000
0
FOR
139352.000000
FOR
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Wendy L. Simpson
DIRECTOR ELECTIONS
ISSUER
139352.000000
0
FOR
139352.000000
FOR
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Timothy J. Triche
DIRECTOR ELECTIONS
ISSUER
139352.000000
0
AGAINST
139352.000000
AGAINST
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Advisory vote to approve named executive officer compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
139352.000000
0
AGAINST
139352.000000
AGAINST
LTC Properties, Inc.
502175102
US5021751020
05/20/2026
Ratification of independent registered public accounting firm.
AUDIT-RELATED
ISSUER
139352.000000
0
AGAINST
139352.000000
AGAINST
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey
DIRECTOR ELECTIONS
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
258774.000000
0
AGAINST
258774.000000
AGAINST
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan.
COMPENSATION
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL").
CORPORATE GOVERNANCE
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL.
CORPORATE GOVERNANCE
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Tandem Diabetes Care, Inc.
875372203
US8753722037
05/20/2026
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
258774.000000
0
FOR
258774.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Marc N. Casper
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Nelson J. Chai
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Ruby R. Chandy
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: C. Martin Harris
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Tyler Jacks
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
AGAINST
55978.000000
AGAINST
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Jennifer M. Johnson
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: R. Alexandra Keith
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Karen S. Lynch
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Debora L. Spar
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Scott M. Sperling
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
AGAINST
55978.000000
AGAINST
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Election of Directors: Dion J. Weisler
DIRECTOR ELECTIONS
ISSUER
55978.000000
0
FOR
55978.000000
FOR
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
An advisory vote to approve named executive officer compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
55978.000000
0
AGAINST
55978.000000
AGAINST
Thermo Fisher Scientific Inc.
883556102
US8835561023
05/20/2026
Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026.
AUDIT-RELATED
ISSUER
55978.000000
0
AGAINST
55978.000000
AGAINST
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Paul M. Bisaro
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Vanessa Broadhurst
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Frank A. D'Amelio
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Gavin D.K. Hattersley
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Sanjay Khosla
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Antoinette R. Leatherberry
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Michael B. McCallister
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Gregory Norden
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Kristin C. Peck
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Willie M. Reed
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Mark Stetter
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Election of Directors: Stephanie Tilenius
DIRECTOR ELECTIONS
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Advisory vote to approve our executive compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
189493.000000
0
AGAINST
189493.000000
AGAINST
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Advisory vote to approve the frequency of future advisory votes on our executive compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
189493.000000
0
ONE YEAR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026.
AUDIT-RELATED
ISSUER
189493.000000
0
FOR
189493.000000
FOR
Zoetis Inc.
98978V103
US98978V1035
05/20/2026
Shareholder proposal to permit shareholder action by written consent.
CORPORATE GOVERNANCE
SECURITY HOLDER
189493.000000
0
AGAINST
189493.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Marjorie C. Green
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Michael A. Kelly
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: John P. Kenny
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: David B. Perez
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Felicia Williams
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Election of the directors named in the proxy statement as set forth below: Anthony P. Zook
DIRECTOR ELECTIONS
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
1122042.000000
0
AGAINST
1122042.000000
AGAINST
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.
COMPENSATION
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
NeoGenomics, Inc.
64049M209
US64049M2098
05/21/2026
Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm.
AUDIT-RELATED
ISSUER
1122042.000000
0
FOR
1122042.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H.
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D.
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D.
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D.
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Heather Knight
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
AGAINST
10663.000000
AGAINST
Waters Corporation
941848103
US9418481035
05/21/2026
To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano
DIRECTOR ELECTIONS
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and
AUDIT-RELATED
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Waters Corporation
941848103
US9418481035
05/21/2026
To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
10663.000000
0
FOR
10663.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Kenneth J. Bacon
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Karen B. DeSalvo
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Andrew Gundlach
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Dennis G. Lopez
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Shankh Mitra
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Ade J. Patton
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Sergio D. Rivera
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Johnese M. Spisso
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
Election of Directors: Kathryn M. Sullivan
DIRECTOR ELECTIONS
ISSUER
57915.000000
0
FOR
57915.000000
FOR
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
The ratification of the selection of Ernst & Young LLP as Welltower Inc.'s independent registered public accounting firm for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
57915.000000
0
AGAINST
57915.000000
AGAINST
Welltower Inc.
95040Q104
US95040Q1040
05/21/2026
The approval, on an advisory basis, of the compensation of the named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
57915.000000
0
AGAINST
57915.000000
AGAINST
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Douglas M. Baker, Jr.
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Mary Ellen Coe
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Pamela J. Craig
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Robert M. Davis
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Thomas H. Glocer
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
AGAINST
417254.000000
AGAINST
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Surendralal L. Karsanbhai
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Risa J. Lavizzo-Mourey, M.D.
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Stephen L. Mayo, Ph.D.
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Paul B. Rothman, M.D.
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Patricia F. Russo
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
AGAINST
417254.000000
AGAINST
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Christine E. Seidman, M.D.
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Inge G. Thulin
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Election of Directors: Kathy J. Warden
DIRECTOR ELECTIONS
ISSUER
417254.000000
0
FOR
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Non-binding advisory vote to approve the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
417254.000000
0
AGAINST
417254.000000
AGAINST
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Ratification of the appointment of the Company's independent registered public accounting firm for 2026.
AUDIT-RELATED
ISSUER
417254.000000
0
AGAINST
417254.000000
AGAINST
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Shareholder proposal regarding a report on DEI risks in federal contracting.
ENVIRONMENT OR CLIMATE
DIVERSITY, EQUITY, AND INCLUSION
OTHER SOCIAL ISSUES
SECURITY HOLDER
417254.000000
0
AGAINST
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Shareholder proposal regarding a report on healthcare coverage gaps.
ENVIRONMENT OR CLIMATE
DIVERSITY, EQUITY, AND INCLUSION
OTHER SOCIAL ISSUES
SECURITY HOLDER
417254.000000
0
AGAINST
417254.000000
FOR
Merck & Co., Inc.
58933Y105
US58933Y1055
05/26/2026
Shareholder proposal regarding a report on political contributions.
OTHER SOCIAL ISSUES
SECURITY HOLDER
417254.000000
0
AGAINST
417254.000000
FOR
Cytokinetics, Incorporated
23282W605
US23282W6057
05/27/2026
Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.
DIRECTOR ELECTIONS
ISSUER
65097.000000
0
FOR
65097.000000
FOR
Cytokinetics, Incorporated
23282W605
US23282W6057
05/27/2026
Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D.
DIRECTOR ELECTIONS
ISSUER
65097.000000
0
FOR
65097.000000
FOR
Cytokinetics, Incorporated
23282W605
US23282W6057
05/27/2026
Election of Class I Directors for terms expiring in 2029: Nancy J. Wysenski
DIRECTOR ELECTIONS
ISSUER
65097.000000
0
FOR
65097.000000
FOR
Cytokinetics, Incorporated
23282W605
US23282W6057
05/27/2026
To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock.
COMPENSATION
ISSUER
65097.000000
0
FOR
65097.000000
FOR
Cytokinetics, Incorporated
23282W605
US23282W6057
05/27/2026
To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
65097.000000
0
FOR
65097.000000
FOR
Cytokinetics, Incorporated
23282W605
US23282W6057
05/27/2026
To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
65097.000000
0
FOR
65097.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
AGAINST
87236.000000
AGAINST
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Renee Gala
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer
DIRECTOR ELECTIONS
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
87236.000000
0
FOR
87236.000000
FOR
DexCom, Inc.
252131107
US2521311074
05/27/2026
To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
87236.000000
0
AGAINST
87236.000000
AGAINST
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: Robert W. Chapin, Jr.
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: Tracy M.J. Colden
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: Lilly H. Donohue
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: James R. Jobe
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: Robert A. McCabe, Jr.
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
AGAINST
5596.000000
AGAINST
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: D. Eric Mendelsohn
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Election of Directors: Candice W. Todd
DIRECTOR ELECTIONS
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Approve, on a non-binding advisory basis, the compensation paid to our named executive officers as disclosed in the accompanying Proxy Statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
5596.000000
0
FOR
5596.000000
FOR
National Health Investors, Inc.
63633D104
US63633D1046
05/27/2026
Ratify the audit committee's selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
5596.000000
0
AGAINST
5596.000000
AGAINST
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Saumya Sutaria
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: J. Robert Kerrey
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
AGAINST
12587.000000
AGAINST
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Vineeta Agarwala
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: James L. Bierman
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Roy Blunt
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Richard W. Fisher
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Meghan M. FitzGerald
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Cecil D. Haney
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Christopher S. Lynch
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Richard J. Mark
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Tammy Romo
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Nadja Y. West
DIRECTOR ELECTIONS
ISSUER
12587.000000
0
FOR
12587.000000
FOR
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To vote, on an advisory basis, to approve the Company's executive compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
12587.000000
0
AGAINST
12587.000000
AGAINST
Tenet Healthcare Corporation
88033G407
US88033G4073
05/27/2026
To ratify the selection of Deloitte & Touche LLP as our independent registered public accountants for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
12587.000000
0
FOR
12587.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Charles Baker
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Timothy Flynn
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Paul Garcia
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Kristen Gil
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Scott Gottlieb, M.D.
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Stephen Hemsley
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: F. William McNabb III
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: Valerie Montgomery Rice, M.D.
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Election of Directors: John Noseworthy, M.D.
DIRECTOR ELECTIONS
ISSUER
37141.000000
0
FOR
37141.000000
FOR
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Advisory approval of the Company's executive compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
37141.000000
0
AGAINST
37141.000000
AGAINST
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
37141.000000
0
AGAINST
37141.000000
AGAINST
UnitedHealth Group Incorporated
91324P102
US91324P1021
06/01/2026
If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent.
CORPORATE GOVERNANCE
SECURITY HOLDER
37141.000000
0
AGAINST
37141.000000
FOR
InspireMD, Inc.
45779A846
US45779A8466
06/03/2026
Election of three Class III directors to serve on the Company's board of directors for a term of three years or until his successor is elected and qualified: Marvin Slosman
DIRECTOR ELECTIONS
ISSUER
1059385.000000
0
FOR
1059385.000000
FOR
InspireMD, Inc.
45779A846
US45779A8466
06/03/2026
Election of three Class III directors to serve on the Company's board of directors for a term of three years or until his successor is elected and qualified: Raymond Cohen
DIRECTOR ELECTIONS
ISSUER
1059385.000000
0
WITHHOLD
1059385.000000
AGAINST
InspireMD, Inc.
45779A846
US45779A8466
06/03/2026
Election of three Class III directors to serve on the Company's board of directors for a term of three years or until his successor is elected and qualified: Dan Dearen
DIRECTOR ELECTIONS
ISSUER
1059385.000000
0
WITHHOLD
1059385.000000
AGAINST
InspireMD, Inc.
45779A846
US45779A8466
06/03/2026
To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the authorized shares of common stock from 150,000,000 to 250,000,000.
CAPITAL STRUCTURE
ISSUER
1059385.000000
0
FOR
1059385.000000
FOR
InspireMD, Inc.
45779A846
US45779A8466
06/03/2026
Ratification of the appointment of Kesselman & Kesselman, Certified Public Accountants, a member of PricewaterhouseCoopers International Limited, as the Company's independent registered public accounting firm for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
1059385.000000
0
FOR
1059385.000000
FOR
InspireMD, Inc.
45779A846
US45779A8466
06/03/2026
To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes to establish a quorum or in favor of proposals 1 through 3.
CORPORATE GOVERNANCE
ISSUER
1059385.000000
0
FOR
1059385.000000
FOR
Alignment Healthcare, Inc.
01625V104
US01625V1044
06/04/2026
Election of Directors: Jody Bilney
DIRECTOR ELECTIONS
ISSUER
413043.000000
0
WITHHOLD
413043.000000
AGAINST
Alignment Healthcare, Inc.
01625V104
US01625V1044
06/04/2026
Election of Directors: David Hodgson
DIRECTOR ELECTIONS
ISSUER
413043.000000
0
WITHHOLD
413043.000000
AGAINST
Alignment Healthcare, Inc.
01625V104
US01625V1044
06/04/2026
Election of Directors: Jacqueline Kosecoff
DIRECTOR ELECTIONS
ISSUER
413043.000000
0
WITHHOLD
413043.000000
AGAINST
Alignment Healthcare, Inc.
01625V104
US01625V1044
06/04/2026
Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026
AUDIT-RELATED
ISSUER
413043.000000
0
FOR
413043.000000
FOR
Alignment Healthcare, Inc.
01625V104
US01625V1044
06/04/2026
Approval, on an non-binding, advisory basis, of the compensation of our Named Executive Officers
SECTION 14A SAY-ON-PAY VOTES
ISSUER
413043.000000
0
FOR
413043.000000
FOR
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro
DIRECTOR ELECTIONS
ISSUER
1110404.000000
0
FOR
1110404.000000
FOR
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar
DIRECTOR ELECTIONS
ISSUER
1110404.000000
0
FOR
1110404.000000
FOR
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D.
DIRECTOR ELECTIONS
ISSUER
1110404.000000
0
FOR
1110404.000000
FOR
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.
AUDIT-RELATED
ISSUER
1110404.000000
0
AGAINST
1110404.000000
AGAINST
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
1110404.000000
0
AGAINST
1110404.000000
AGAINST
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan.
COMPENSATION
ISSUER
1110404.000000
0
FOR
1110404.000000
FOR
Myriad Genetics, Inc.
62855J104
US62855J1043
06/04/2026
To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan.
COMPENSATION
ISSUER
1110404.000000
0
FOR
1110404.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. Ingram
DIRECTOR ELECTIONS
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Hans Wigzell, M.D., Ph.D.
DIRECTOR ELECTIONS
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Kathryn J. Boor, Ph.D.
DIRECTOR ELECTIONS
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael Chambers
DIRECTOR ELECTIONS
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre Connelly
DIRECTOR ELECTIONS
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
Advisory vote to approve, on a non-binding basis, named executive officer compensation
SECTION 14A SAY-ON-PAY VOTES
ISSUER
961017.000000
0
AGAINST
961017.000000
AGAINST
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
Approve the Company's 2026 Equity Incentive Plan
COMPENSATION
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
Approve the Company's 2026 Employee Stock Purchase Plan
COMPENSATION
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sarepta Therapeutics, Inc.
803607100
US8036071004
06/04/2026
Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026
AUDIT-RELATED
ISSUER
961017.000000
0
FOR
961017.000000
FOR
Sera Prognostics, Inc.
81749D107
US81749D1072
06/04/2026
Election of Directors: Kim Kamdar, Ph.D.
DIRECTOR ELECTIONS
ISSUER
1254982.000000
0
WITHHOLD
1254982.000000
AGAINST
Sera Prognostics, Inc.
81749D107
US81749D1072
06/04/2026
Election of Directors: Sandra A.J. Lawrence
DIRECTOR ELECTIONS
ISSUER
1254982.000000
0
FOR
1254982.000000
FOR
Sera Prognostics, Inc.
81749D107
US81749D1072
06/04/2026
Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
1254982.000000
0
FOR
1254982.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Kapila K. Anand
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Craig R. Callen
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Dr. Lisa C. Egbuonu-Davis
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Barbara B. Hill
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
AGAINST
297889.000000
AGAINST
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Kevin J. Jacobs
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: C. Taylor Pickett
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Stephen D. Plavin
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
AGAINST
297889.000000
AGAINST
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Election of Directors: Burke W. Whitman
DIRECTOR ELECTIONS
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for year ending December 31, 2026
AUDIT-RELATED
ISSUER
297889.000000
0
AGAINST
297889.000000
AGAINST
Omega Healthcare Investors, Inc.
681936100
US6819361006
06/05/2026
Approval, on an advisory basis, of the compensation of the named executive officers
SECTION 14A SAY-ON-PAY VOTES
ISSUER
297889.000000
0
FOR
297889.000000
FOR
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Independent Trustee): Alan Felder
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
FOR
293879.000000
FOR
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Independent Trustee): Lisa Harris Jones
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
WITHHOLD
293879.000000
AGAINST
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Independent Trustee): Phyllis M. Hollis
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
FOR
293879.000000
FOR
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Independent Trustee): Dawn K. Neher
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
FOR
293879.000000
FOR
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Independent Trustee): Jeffrey P. Somers
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
WITHHOLD
293879.000000
AGAINST
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Managing Trustee): Christopher J. Bilotto
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
FOR
293879.000000
FOR
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Election of Trustees. Nominees (for Managing Trustee): Adam Portnoy
DIRECTOR ELECTIONS
ISSUER
293879.000000
0
WITHHOLD
293879.000000
AGAINST
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Advisory vote to approve executive compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
293879.000000
0
AGAINST
293879.000000
AGAINST
Diversified Healthcare Trust
25525P107
US25525P1075
06/10/2026
Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2026 fiscal year.
AUDIT-RELATED
ISSUER
293879.000000
0
FOR
293879.000000
FOR
Perceptive Capital Solutions Corp.
35661P100
US35661P1003
06/10/2026
The Extension Amendment Proposal - RESOLVED, as a special resolution that: a) Article 38.8 of PCSC's Amended and Restated Memorandum and Articles of Association be deleted in its entirety and replaced with the following new Article 38.8: "In the event that the Company does not consummate a Business Combination by June 13, 2027, such earlier time as the directors may approve or such later time as the Members of the Company may approve in accordance with the Articles (in any case, such date being referred to as the "Termination Date"), the Company shall: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company for Permitted Withdrawals (less up to US$100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares in issue, which redemption will completely extinguish public Members' rights as Members (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining Members and the directors, liquidate and dissolve, subject in the case of sub-articles (ii) and (iii), to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of Applicable Law. If the Company shall wind up for any other reason prior to the consummation of a Business Combination, the Company shall, as promptly as reasonably possible but not more than ten business days thereafter, follow the foregoing procedures set out in this Article 38.8 with respect to the liquidation of the Trust Account, subject to its obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of Applicable Law." b) Article 38.9 of PCSC's Amended and Restated Memorandum and Articles of Association be deleted in its entirety and replaced with the following new Article 38.9: In the event that any amendment is made to these Articles: (a) that would modify the substance or timing of the Company's obligation to provide holders of Public Shares the right to: (i) have their shares redeemed or repurchased in connection with a Business Combination pursuant to Articles 38.2(b) or 38.6; or (ii) redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within thirty-six (36) months after the date of the closing of the IPO pursuant to Article 38.8; or (b) with respect to any other provision relating to the rights of holders of Public Shares, each holder of Public Shares who is not a Founder, officer or director shall be provided with the opportunity to redeem their Public Shares following the approval, and upon the implementation by the directors, of any such amendment (an Amendment Redemption) at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less Permitted Withdrawals), divided by the number of then-outstanding Public Shares in issue."
CORPORATE GOVERNANCE
ISSUER
355447.000000
0
FOR
355447.000000
FOR
Perceptive Capital Solutions Corp.
35661P100
US35661P1003
06/10/2026
The Adjournment Proposal - RESOLVED, as an ordinary resolution, that the adjournment of the Shareholder Meeting to a later date or dates if necessary, (i) to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Shareholder Meeting, there are insufficient Class A ordinary shares, par value $0.0001 per share (the "Public Shares") and Class B ordinary shares, par value $0.0001 per share in the capital of PCSC represented (either in person or by proxy) to approve the Extension Amendment Proposal, or (ii) if the holders of Public Shares have elected to redeem an amount of shares in connection with the Extension Amendment Proposal such that PCSC would not adhere to the continued listing requirements of the Nasdaq Stock Market LLC
CORPORATE GOVERNANCE
ISSUER
355447.000000
0
FOR
355447.000000
FOR
Praxis Precision Medicines, Inc.
74006W207
US74006W2070
06/10/2026
To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden
DIRECTOR ELECTIONS
ISSUER
44768.000000
0
FOR
44768.000000
FOR
Praxis Precision Medicines, Inc.
74006W207
US74006W2070
06/10/2026
To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza
DIRECTOR ELECTIONS
ISSUER
44768.000000
0
FOR
44768.000000
FOR
Praxis Precision Medicines, Inc.
74006W207
US74006W2070
06/10/2026
To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young
DIRECTOR ELECTIONS
ISSUER
44768.000000
0
WITHHOLD
44768.000000
AGAINST
Praxis Precision Medicines, Inc.
74006W207
US74006W2070
06/10/2026
To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
44768.000000
0
FOR
44768.000000
FOR
Praxis Precision Medicines, Inc.
74006W207
US74006W2070
06/10/2026
To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
44768.000000
0
FOR
44768.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Adoption of the 2025 Dutch statutory annual accounts for the fiscal year ended December 31, 2025.
CORPORATE GOVERNANCE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2025.
CORPORATE GOVERNANCE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Reappointment of Madhavan Balachandran as non-executive director.
DIRECTOR ELECTIONS
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Reappointment of Jack Kaye as non-executive director.
DIRECTOR ELECTIONS
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Reappointment of Leonard Post, Ph.D. as non-executive director.
DIRECTOR ELECTIONS
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Designation of the Board as the competent body to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares.
CAPITAL STRUCTURE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares.
CAPITAL STRUCTURE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Reauthorization of the Board to repurchase Ordinary Shares.
CAPITAL STRUCTURE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Appointment of KPMG Accountants N.V. as external auditor of the Company for the fiscal year 2026.
AUDIT-RELATED
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Approval, on an advisory basis, of the compensation of the named executive officers of the Company.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
966847.000000
0
ONE YEAR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan.
COMPENSATION
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Resolution to adopt the amendment to the Articles of Association to reflect Dutch large company regime.
CORPORATE GOVERNANCE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Resolution to adopt the amendment to the Articles of Association to increase the authorized share capital and number of Ordinary Shares.
CAPITAL STRUCTURE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
uniQure N.V.
N90064101
NL0010696654
06/10/2026
Resolution to adopt the amendment to the Articles of Association to include a federal forum selection provision.
SHAREHOLDER RIGHTS AND DEFENSES
CORPORATE GOVERNANCE
ISSUER
966847.000000
0
FOR
966847.000000
FOR
Arcus Biosciences, Inc.
03969F109
US03969F1093
06/11/2026
Election of Directors: Dietmar Berger, M.D., Ph.D.
DIRECTOR ELECTIONS
ISSUER
266041.000000
0
WITHHOLD
266041.000000
AGAINST
Arcus Biosciences, Inc.
03969F109
US03969F1093
06/11/2026
Election of Directors: David Lacey, M.D.
DIRECTOR ELECTIONS
ISSUER
266041.000000
0
WITHHOLD
266041.000000
AGAINST
Arcus Biosciences, Inc.
03969F109
US03969F1093
06/11/2026
Election of Directors: Nicole Lambert
DIRECTOR ELECTIONS
ISSUER
266041.000000
0
WITHHOLD
266041.000000
AGAINST
Arcus Biosciences, Inc.
03969F109
US03969F1093
06/11/2026
Election of Directors: Johanna Mercier
DIRECTOR ELECTIONS
ISSUER
266041.000000
0
WITHHOLD
266041.000000
AGAINST
Arcus Biosciences, Inc.
03969F109
US03969F1093
06/11/2026
To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
266041.000000
0
FOR
266041.000000
FOR
Arcus Biosciences, Inc.
03969F109
US03969F1093
06/11/2026
To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
266041.000000
0
AGAINST
266041.000000
AGAINST
BioCryst Pharmaceuticals, Inc.
09058V103
US09058V1035
06/11/2026
Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Theresa M. Heggie
DIRECTOR ELECTIONS
ISSUER
1960732.000000
0
FOR
1960732.000000
FOR
BioCryst Pharmaceuticals, Inc.
09058V103
US09058V1035
06/11/2026
Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Amy E. Mckee, M.D.
DIRECTOR ELECTIONS
ISSUER
1960732.000000
0
FOR
1960732.000000
FOR
BioCryst Pharmaceuticals, Inc.
09058V103
US09058V1035
06/11/2026
Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Jon P. Stonehouse
DIRECTOR ELECTIONS
ISSUER
1960732.000000
0
FOR
1960732.000000
FOR
BioCryst Pharmaceuticals, Inc.
09058V103
US09058V1035
06/11/2026
To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026.
AUDIT-RELATED
ISSUER
1960732.000000
0
FOR
1960732.000000
FOR
BioCryst Pharmaceuticals, Inc.
09058V103
US09058V1035
06/11/2026
To hold a non-binding, advisory vote regarding executive compensation.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
1960732.000000
0
FOR
1960732.000000
FOR
BioCryst Pharmaceuticals, Inc.
09058V103
US09058V1035
06/11/2026
To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.
COMPENSATION
ISSUER
1960732.000000
0
FOR
1960732.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Election of Directors: Fred E. Cohen, M.D., D. Phil
DIRECTOR ELECTIONS
ISSUER
249222.000000
0
WITHHOLD
249222.000000
AGAINST
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Election of Directors: R. Bryan Riggsbee
DIRECTOR ELECTIONS
ISSUER
249222.000000
0
FOR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Election of Directors: Suresh Gunasekaran
DIRECTOR ELECTIONS
ISSUER
249222.000000
0
FOR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Election of Directors: Michael D. Goldberg
DIRECTOR ELECTIONS
ISSUER
249222.000000
0
FOR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Election of Directors: John W. Hanna
DIRECTOR ELECTIONS
ISSUER
249222.000000
0
FOR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
249222.000000
0
FOR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Approval, on an advisory basis, of the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
249222.000000
0
FOR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
249222.000000
0
ONE YEAR
249222.000000
FOR
CareDx, Inc.
14167L103
US14167L1035
06/11/2026
Approval of an amendment to the 2024 Equity Incentive Plan.
COMPENSATION
ISSUER
249222.000000
0
FOR
249222.000000
FOR
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Election of Directors: Joseph L. Goldstein, M.D.
DIRECTOR ELECTIONS
ISSUER
6564.000000
0
AGAINST
6564.000000
AGAINST
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Election of Directors: Christine A. Poon
DIRECTOR ELECTIONS
ISSUER
6564.000000
0
AGAINST
6564.000000
AGAINST
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Election of Directors: David P. Schenkein, M.D.
DIRECTOR ELECTIONS
ISSUER
6564.000000
0
FOR
6564.000000
FOR
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Election of Directors: Craig B. Thompson, M.D.
DIRECTOR ELECTIONS
ISSUER
6564.000000
0
AGAINST
6564.000000
AGAINST
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Election of Directors: Huda Y. Zoghbi, M.D.
DIRECTOR ELECTIONS
ISSUER
6564.000000
0
FOR
6564.000000
FOR
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
6564.000000
0
FOR
6564.000000
FOR
Regeneron Pharmaceuticals, Inc.
75886F107
US75886F1075
06/12/2026
Proposal to approve, on an advisory basis, compensation of the Named Executive Officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
6564.000000
0
FOR
6564.000000
FOR
Vaxcyte, Inc.
92243G108
US92243G1085
06/15/2026
Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.
DIRECTOR ELECTIONS
ISSUER
54750.000000
0
WITHHOLD
54750.000000
AGAINST
Vaxcyte, Inc.
92243G108
US92243G1085
06/15/2026
Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D.
DIRECTOR ELECTIONS
ISSUER
54750.000000
0
WITHHOLD
54750.000000
AGAINST
Vaxcyte, Inc.
92243G108
US92243G1085
06/15/2026
Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A.
DIRECTOR ELECTIONS
ISSUER
54750.000000
0
FOR
54750.000000
FOR
Vaxcyte, Inc.
92243G108
US92243G1085
06/15/2026
Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
54750.000000
0
FOR
54750.000000
FOR
Vaxcyte, Inc.
92243G108
US92243G1085
06/15/2026
Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
54750.000000
0
FOR
54750.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Craig A. Barbarosh
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
AGAINST
530480.000000
AGAINST
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Katie Cusack
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
FOR
530480.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Michael J. Foster
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
AGAINST
530480.000000
AGAINST
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Lynne S. Katzmann
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
FOR
530480.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Ann Kono
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
FOR
530480.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Jeffrey A. Malehorn
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
FOR
530480.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Election of Directors: Richard K. Matros
DIRECTOR ELECTIONS
ISSUER
530480.000000
0
FOR
530480.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
530480.000000
0
FOR
530480.000000
FOR
Sabra Health Care REIT, Inc.
78573L106
US78573L1061
06/17/2026
Approval, on an advisory basis, of the compensation of Sabra's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
530480.000000
0
AGAINST
530480.000000
AGAINST
Disc Medicine, Inc.
254604101
US2546041011
06/18/2026
To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.
DIRECTOR ELECTIONS
ISSUER
86107.000000
0
WITHHOLD
86107.000000
AGAINST
Disc Medicine, Inc.
254604101
US2546041011
06/18/2026
To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.
DIRECTOR ELECTIONS
ISSUER
86107.000000
0
FOR
86107.000000
FOR
Disc Medicine, Inc.
254604101
US2546041011
06/18/2026
To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.
DIRECTOR ELECTIONS
ISSUER
86107.000000
0
FOR
86107.000000
FOR
Disc Medicine, Inc.
254604101
US2546041011
06/18/2026
To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
86107.000000
0
FOR
86107.000000
FOR
Disc Medicine, Inc.
254604101
US2546041011
06/18/2026
To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
86107.000000
0
FOR
86107.000000
FOR
GeneDx Holdings Corp.
81663L200
US81663L2007
06/18/2026
Election of Director: Katherine Stueland
DIRECTOR ELECTIONS
ISSUER
92816.000000
0
FOR
92816.000000
FOR
GeneDx Holdings Corp.
81663L200
US81663L2007
06/18/2026
Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
92816.000000
0
FOR
92816.000000
FOR
GeneDx Holdings Corp.
81663L200
US81663L2007
06/18/2026
Approval, on a non-binding advisory basis, the compensation of our named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
92816.000000
0
FOR
92816.000000
FOR
GeneDx Holdings Corp.
81663L200
US81663L2007
06/18/2026
Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
92816.000000
0
ONE YEAR
92816.000000
FOR
Revolution Medicines, Inc.
76155X100
US76155X1000
06/18/2026
To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis Borisy
DIRECTOR ELECTIONS
ISSUER
11592.000000
0
WITHHOLD
11592.000000
AGAINST
Revolution Medicines, Inc.
76155X100
US76155X1000
06/18/2026
To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D.
DIRECTOR ELECTIONS
ISSUER
11592.000000
0
FOR
11592.000000
FOR
Revolution Medicines, Inc.
76155X100
US76155X1000
06/18/2026
To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; and
AUDIT-RELATED
ISSUER
11592.000000
0
FOR
11592.000000
FOR
Revolution Medicines, Inc.
76155X100
US76155X1000
06/18/2026
To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").
SECTION 14A SAY-ON-PAY VOTES
ISSUER
11592.000000
0
FOR
11592.000000
FOR
ARS Pharmaceuticals, Inc.
82835W108
US82835W1080
06/24/2026
To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D.
DIRECTOR ELECTIONS
ISSUER
1783628.000000
0
FOR
1783628.000000
FOR
ARS Pharmaceuticals, Inc.
82835W108
US82835W1080
06/24/2026
To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider
DIRECTOR ELECTIONS
ISSUER
1783628.000000
0
WITHHOLD
1783628.000000
AGAINST
ARS Pharmaceuticals, Inc.
82835W108
US82835W1080
06/24/2026
To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D.
DIRECTOR ELECTIONS
ISSUER
1783628.000000
0
FOR
1783628.000000
FOR
ARS Pharmaceuticals, Inc.
82835W108
US82835W1080
06/24/2026
To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.
AUDIT-RELATED
ISSUER
1783628.000000
0
FOR
1783628.000000
FOR
ARS Pharmaceuticals, Inc.
82835W108
US82835W1080
06/24/2026
To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
1783628.000000
0
AGAINST
1783628.000000
AGAINST
ARS Pharmaceuticals, Inc.
82835W108
US82835W1080
06/24/2026
To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.
SECTION 14A SAY-ON-PAY VOTES
ISSUER
1783628.000000
0
ONE YEAR
1783628.000000
FOR
Lucid Diagnostics Inc.
54948X109
US54948X1090
06/24/2026
Election of Class B Directors: James L. Cox, M.D.
DIRECTOR ELECTIONS
ISSUER
3514366.000000
0
WITHHOLD
3514366.000000
AGAINST
Lucid Diagnostics Inc.
54948X109
US54948X1090
06/24/2026
Election of Class B Directors: John R. Palumbo
DIRECTOR ELECTIONS
ISSUER
3514366.000000
0
WITHHOLD
3514366.000000
AGAINST
Lucid Diagnostics Inc.
54948X109
US54948X1090
06/24/2026
Election of Class B Directors: Ronald M. Sparks
DIRECTOR ELECTIONS
ISSUER
3514366.000000
0
WITHHOLD
3514366.000000
AGAINST
Lucid Diagnostics Inc.
54948X109
US54948X1090
06/24/2026
Approval of an amendment to the Certificate of Incorporation to increase the total number of shares of common stock the Company is authorized to issue by 100,000,000 shares, from 300,000,000 shares to 400,000,000 shares.
CAPITAL STRUCTURE
ISSUER
3514366.000000
0
FOR
3514366.000000
FOR
Lucid Diagnostics Inc.
54948X109
US54948X1090
06/24/2026
Ratification of the appointment of the independent registered certified public accounting firm.
AUDIT-RELATED
ISSUER
3514366.000000
0
FOR
3514366.000000
FOR